Samsara Bio Capital, LLC Leap Therapeutics, Inc. Transaction History

Samsara Bio Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.3 - $4.46 $253,811 - $3.77 Million	-846,038 Closed	0 $0
Q1 2023 Aug 14, 2023	SELL	$0.29 - $0.72 $1.7 Million - $4.21 Million	-5,847,000 Reduced 87.36%	846,038 $287,000
Q1 2023 May 15, 2023	BUY	$0.29 - $0.72 $1.94 Million - $4.82 Million	6,693,038 New	6,693,038 $2.28 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $263M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.